Corrimont Medical
Two plants became one without a missed shipment or a failed audit.
Plant consolidation
·
16 weeks

Medical devices
·
2024
Corrimont Medical
Two plants became one without a missed shipment or a failed audit.
Plant consolidation
·
16 weeks

Medical devices
·
2024
Corrimont Medical
Two plants became one without a missed shipment or a failed audit.
Plant consolidation
·
16 weeks

Medical devices
·
2024
■ About the client
Corrimont makes single-use surgical devices for hospitals across Europe. It ran two ageing plants forty miles apart, each of them half full.
■ About the client
Corrimont makes single-use surgical devices for hospitals across Europe. It ran two ageing plants forty miles apart, each of them half full.
■ About the client
Corrimont makes single-use surgical devices for hospitals across Europe. It ran two ageing plants forty miles apart, each of them half full.
Client
Corrimont Medical
Medical devices
2→1
Plants, no missed shipments
Brief
Consolidate two plants into one without a missed shipment or a failed audit.
Production moved in four waves over sixteen weeks. Every shipment left on time and both regulatory audits passed first time.
Outcome
Client
Corrimont Medical
Medical devices
2→1
Plants, no missed shipments
Brief
Consolidate two plants into one without a missed shipment or a failed audit.
Production moved in four waves over sixteen weeks. Every shipment left on time and both regulatory audits passed first time.
Outcome
Client
Corrimont Medical
Medical devices
2→1
Plants, no missed shipments
Brief
Consolidate two plants into one without a missed shipment or a failed audit.
Production moved in four waves over sixteen weeks. Every shipment left on time and both regulatory audits passed first time.
Outcome
The brief
Corrimont’s board had approved the move twice and stopped it twice. Each time, the risk to regulated production looked too large to plan around.
The brief
Corrimont’s board had approved the move twice and stopped it twice. Each time, the risk to regulated production looked too large to plan around.
The brief
Corrimont’s board had approved the move twice and stopped it twice. Each time, the risk to regulated production looked too large to plan around.
What we did
We built the move line by line with the plant managers, sequenced it in four waves around stock builds, and ran a validation plan the quality team signed before a single machine moved.
What we did
We built the move line by line with the plant managers, sequenced it in four waves around stock builds, and ran a validation plan the quality team signed before a single machine moved.
What we did
We built the move line by line with the plant managers, sequenced it in four waves around stock builds, and ran a validation plan the quality team signed before a single machine moved.
What held
The second plant closed on schedule. Output per shift is up eleven per cent, and the site passed its first audit after the move with no findings.
What held
The second plant closed on schedule. Output per shift is up eleven per cent, and the site passed its first audit after the move with no findings.
What held
The second plant closed on schedule. Output per shift is up eleven per cent, and the site passed its first audit after the move with no findings.
“
Corrimont Medical
They planned it with the people who run the lines, which is why it worked.
Henrik Aalto
Plant Director
“
Corrimont Medical
They planned it with the people who run the lines, which is why it worked.
Henrik Aalto
Plant Director
“
Corrimont Medical
They planned it with the people who run the lines, which is why it worked.
Henrik Aalto
Plant Director
